Literature DB >> 17530423

Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value.

Siri Tveito1, Gunhild M Maelandsmo, Hanne K Hoifodt, Heidi Rasmussen, Oystein Fodstad.   

Abstract

Molecular studies of rare cells, such as circulating cancer cells, require efficient pre-enrichment steps to obtain a pure population of target cells for further characterization. We have developed a two-step approach, starting with immunomagnetic enrichment, followed by specific isolation of individual, easily identifiable bead-rosetted target cells using a new semi-automated CellPick system. With this procedure, 1-50 live target cells can now be isolated. As a model system, we spiked a small number of tumor cells into millions of normal mononuclear cells (MNCs). Efficient isolation of pure target cells was obtained by use of the CellPick system, and the nature of isolated, bead-rosetted cells was verified by use of FISH. Single breast cancer cells were picked directly into an RNA preserving lysis buffer, reverse transcribed, and PCR amplified with two cDNA specific primer sets. With the isolated cells we consistently obtained both ubiquitously expressed and tumor cell specific PCR products. We also performed a successful mutation analysis of single cells using PCR and cycling temperature capillary electrophoresis (CTCE). This may have significant clinical implications in cancer and in other diseases, e.g. in characterizing micrometastatic cancer cells in blood and lymph nodes to help identifying patients who most likely will respond to therapies like tyrosine kinase inhibitors and compounds targeting specific mutations. By use of the CellPick system it is possible to specifically isolate bead-rosetted or otherwise labelled target cells from a heterogeneous cell population for further molecular characterization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530423     DOI: 10.1007/s10585-006-9052-8

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  35 in total

1.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

2.  Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma.

Authors:  S Leinung; P Würl; C L Weiss; I Röder; M Schönfelder
Journal:  Langenbecks Arch Surg       Date:  2000-08       Impact factor: 3.445

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.

Authors:  Kristin Bjørnland; Kjersti Flatmark; Tom Mala; Oystein Mathisen; Arne Bakka; Ansgar O Aasen; Anstein Bergan; Odd Søreide; Oystein Fodstad
Journal:  J Surg Oncol       Date:  2003-04       Impact factor: 3.454

5.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

6.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.

Authors:  K J Luzzi; I C MacDonald; E E Schmidt; N Kerkvliet; V L Morris; A F Chambers; A C Groom
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

7.  Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.

Authors:  G Wiedswang; E Borgen; R Kåresen; G Kvalheim; J M Nesland; H Qvist; E Schlichting; T Sauer; J Janbu; T Harbitz; B Naume
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

8.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

Authors:  K Pantel; J Izbicki; B Passlick; M Angstwurm; K Häussinger; O Thetter; G Riethmüller
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

9.  Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.

Authors:  Ragnar S Faye; Steinar Aamdal; Hanne K Høifødt; Erling Jacobsen; Linn Holstad; Eva Skovlund; Øystein Fodstad
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

10.  From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.

Authors:  Oleg Schmidt-Kittler; Thomas Ragg; Angela Daskalakis; Martin Granzow; Andre Ahr; Thomas J F Blankenstein; Manfred Kaufmann; Joachim Diebold; Hans Arnholdt; Peter Muller; Joachim Bischoff; Detlev Harich; Gunter Schlimok; Gert Riethmuller; Roland Eils; Christoph A Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  10 in total

1.  Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.

Authors:  Hanmant Gaikwad; Yue Li; Geoffrey Gifford; Ernest Groman; Nirmal K Banda; Laura Saba; Robert Scheinman; Guankui Wang; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2020-06-29       Impact factor: 4.774

Review 2.  Assessment of tumor response to tyrosine kinase inhibitors.

Authors:  Amanda Lowery; Zhaozhong Han
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

3.  Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling.

Authors:  Ase Bratland; Piet J Boender; Hanne K Høifødt; Ingrid H G Østensen; Rob Ruijtenbeek; Meng-Yu Wang; Jens P Berg; Wolfgang Lilleby; Øystein Fodstad; Anne Hansen Ree
Journal:  Clin Exp Metastasis       Date:  2009-03-18       Impact factor: 5.150

4.  Current concepts of metastasis in melanoma.

Authors:  Blazej Zbytek; J Andrew Carlson; Jacqueline Granese; Jeffrey Ross; Martin C Mihm; Andrzej Slominski
Journal:  Expert Rev Dermatol       Date:  2008-10

5.  Isolation of rare cells from cell mixtures by dielectrophoresis.

Authors:  Peter R C Gascoyne; Jamileh Noshari; Thomas J Anderson; Frederick F Becker
Journal:  Electrophoresis       Date:  2009-04       Impact factor: 3.535

6.  Binding and isolation of tumor cells in biological media with perfluorocarbon microbubbles.

Authors:  Guixin Shi; Wenjin Cui; Rajesh Mukthavaram; Yu-Tsueng Liu; Dmitri Simberg
Journal:  Methods       Date:  2013-08-22       Impact factor: 3.608

7.  Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.

Authors:  Geir Olav Hjortland; Leonardo A Meza-Zepeda; Klaus Beiske; Anne H Ree; Siri Tveito; Hanne Hoifodt; Per J Bohler; Knut H Hole; Ola Myklebost; Oystein Fodstad; Sigbjorn Smeland; Eivind Hovig
Journal:  BMC Cancer       Date:  2011-10-20       Impact factor: 4.430

8.  Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.

Authors:  Siri Tveito; Kristin Andersen; Rolf Kåresen; Øystein Fodstad
Journal:  Breast Cancer Res       Date:  2011-08-04       Impact factor: 6.466

9.  Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles.

Authors:  Guixin Shi; Wenjin Cui; Michael Benchimol; Yu-Tsueng Liu; Robert F Mattrey; Rajesh Mukthavaram; Santosh Kesari; Sadik C Esener; Dmitri Simberg
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

10.  Efficacy and feasibility of the epithelial cell adhesion molecule (EpCAM) immunomagnetic cell sorter for studies of DNA methylation in colorectal cancer.

Authors:  Alessandra Failli; Annalisa Legitimo; Francesca Migheli; Fabio Coppedè; John C Mathers; Roberto Spisni; Paolo Miccoli; Lucia Migliore; Rita Consolini
Journal:  Int J Mol Sci       Date:  2013-12-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.